发明公开
EP2097380A1 NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES
审中-公开
新的卤代烷基取代的化合物可用于治疗肥胖和糖尿病
- 专利标题： NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES
- 专利标题（中）： 新的卤代烷基取代的化合物可用于治疗肥胖和糖尿病
-
申请号： EP07847179.4申请日： 2007-11-15
-
公开(公告)号： EP2097380A1公开(公告)日： 2009-09-09
- 发明人: OLESEN, Preben Houlberg , PETERSEN, Anders Klarskov , NIELSEN, Flemming Elmelund , CHRISTIANSEN, Lise Brown
- 申请人： High Point Pharmaceuticals, LLC
- 申请人地址： 4170 Mendenhall Oaks Parkway High Point, NC 27265 US
- 专利权人： High Point Pharmaceuticals, LLC
- 当前专利权人： High Point Pharmaceuticals, LLC
- 当前专利权人地址： 4170 Mendenhall Oaks Parkway High Point, NC 27265 US
- 代理机构： Bailey, Lindsey
- 优先权： DK200601485 20061115
- 国际公布： WO2008059023 20080522
- 主分类号： C07D213/56
- IPC分类号： C07D213/56 ; C07D261/08 ; A61K31/5355 ; A61P3/04
摘要：
The present invention relates to novel compounds of formula [I], wherein R1 represernts heteroaryl, at least one substituent among R5, R6 and R7 represent -SR12, -S(O)R12 or -S(O)2R12 and the remaining substituents are as defined in the claims, that act as chemical uncouplers. Compounds of the invention are useful inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases associated therewith.
信息查询
